Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.09.038Source: DataRank Database

Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.44)OA: hybridTopics (18)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Roberto Salgado ORCID,Julia White ORCID,Bruce F. Kimler ORCID,Rachel Yoder ORCID,Joshua M. Staley ORCID

Live enrichment

PubMed:41015093 OpenAlex:https://openalex.org/W4414558013

National Institute of General Medical Sciences

Grant: P20 GM130423

National Institutes of Health National Cancer Institute

Grant: P30 CA168524

NCATS NIH HHS

Grant: KL2 TR002367

National Institutes of Health

National Center for Advancing Translational Sciences

Merck

University of Kansas

The University of Kansas Medical Center

American Cancer Society Inc

FWCI

0.44

Citation Percentile

0.6%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.ijrobp.2025.09.038

publisherhttps://doi.org/10.1016/j.ijrobp.2025.09.038

publisherhttps://api.elsevier.com/content/article/PII:S0360301625063023?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0360301625063023?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41015093

Fields of Study

Breast Cancer Treatment StudiesInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and Biomarkers

MeSH Terms

AdultAgedAlgorithmsFemaleHumansMiddle AgedRadiation ToleranceLymphocytes, Tumor-InfiltratingNeoadjuvant TherapyTriple Negative Breast Neoplasms

Keywords

RadiosensitivityBreast cancerImmune systemCancerOverall survival